Open Access

Overexpression of non‑SMC condensin I complex subunit G serves as a promising prognostic marker and therapeutic target for hepatocellular carcinoma

  • Authors:
    • Wanwei Liu
    • Bo Liang
    • Hongliang Liu
    • Yong Huang
    • Xiangbao Yin
    • Fan Zhou
    • Xin Yu
    • Qian Feng
    • Enliang Li
    • Zhenhong Zou
    • Linquan Wu
  • View Affiliations

  • Published online on: July 24, 2017     https://doi.org/10.3892/ijmm.2017.3079
  • Pages: 731-738
  • Copyright: © Liu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The non‑SMC condensin I complex subunit G (NCAPG) that organizes the coiling topology of individual chromatids, represents an overexpressed antigen in various types of cancer, and also contributes to restructuring chromatin into rod‑shaped mitotic chromosomes and ensuring the segregation of sister chromatid during cell division. In this study, we investigated the association between NCAPG expression and the biological behavior of hepatocellular carcinoma (HCC) to further explore the potential of NCAPG as a therapeutic target. The expression of NCAPG was detected in human HCC cell lines and tumor samples. The effects of NCAPG on the cell cycle, apoptosis and metastasis were investigated by various assays. NCAPG was found to be overexpressed in HCC compared with the adjacent normal tissue (P<0.001), and high levels of NCAPG expression were found to significantly correlate with recurrence, the time of recurrence, metastasis, differentiation and TNM stage. Furthermore, an elevated expression of NCAPG was associated with a poor overall survival (P<0.05). In addition, in vitro experiments further confirmed the ex vivo data; i.e., the knockdown of NCAPG expression reduced HCC cell viability, but induced apoptosis and arrested the cells at the S phase of the cell cycle. The knockdown of NCAPG expression also inhibited tumor cell migration and the cell invasive capacity in vitro. At the protein level, the knockdown of NCAPG expression upregulated Bax, cleaved caspase‑3 and E‑cadherin, but downregulated cyclin A1, CDK2, Bcl‑2, N‑cadherin and HOXB9 expression, suggesting that the knockdown of NCAPG expression suppressed tumor cell epithelial‑mesenchymal transition. On the whole, this study demonstrates that NCAPG plays an important role in the development and progression of HCC, and that it may be a novel therapeutic target for patients with HCC.
View Figures
View References

Related Articles

Journal Cover

September-2017
Volume 40 Issue 3

Print ISSN: 1107-3756
Online ISSN:1791-244X

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Liu W, Liang B, Liu H, Huang Y, Yin X, Zhou F, Yu X, Feng Q, Li E, Zou Z, Zou Z, et al: Overexpression of non‑SMC condensin I complex subunit G serves as a promising prognostic marker and therapeutic target for hepatocellular carcinoma. Int J Mol Med 40: 731-738, 2017
APA
Liu, W., Liang, B., Liu, H., Huang, Y., Yin, X., Zhou, F. ... Wu, L. (2017). Overexpression of non‑SMC condensin I complex subunit G serves as a promising prognostic marker and therapeutic target for hepatocellular carcinoma. International Journal of Molecular Medicine, 40, 731-738. https://doi.org/10.3892/ijmm.2017.3079
MLA
Liu, W., Liang, B., Liu, H., Huang, Y., Yin, X., Zhou, F., Yu, X., Feng, Q., Li, E., Zou, Z., Wu, L."Overexpression of non‑SMC condensin I complex subunit G serves as a promising prognostic marker and therapeutic target for hepatocellular carcinoma". International Journal of Molecular Medicine 40.3 (2017): 731-738.
Chicago
Liu, W., Liang, B., Liu, H., Huang, Y., Yin, X., Zhou, F., Yu, X., Feng, Q., Li, E., Zou, Z., Wu, L."Overexpression of non‑SMC condensin I complex subunit G serves as a promising prognostic marker and therapeutic target for hepatocellular carcinoma". International Journal of Molecular Medicine 40, no. 3 (2017): 731-738. https://doi.org/10.3892/ijmm.2017.3079